Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

Completed

Conditions studied: Urinary Tract Infection, Complicated, Acute Pyelonephritis, Hospital Acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, Bacteremia

In brief

A multi-center, retrospective study of cases of serious bacterial infections including complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP), Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Acquired Bacterial Pneumonia (VABP), and/or bacteremia caused by Carbapenem-Resistant Enterobacteriaceae (CRE)

Key facts

Study ID

NCT02420366

Run by

Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

People needed

257

Starts

2014-05-01

Expected to finish

2015-01-01

Last updated by the study team

2018-05-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female ≥18 years of age.
• Carbapenem resistant Enterobacteriaceae (CRE) must be identified in the urine, blood or respiratory tract samples submitted for culture in the setting of cUTI or AP, HABP, VABP, and/or bacteremia.
• Diagnosis with either cUTI or AP, HABP, VABP, and/or bacteremia.

You may not qualify if…

• none

Where it is running

• Study site — Chicago, Illinois, United States
• Study site — Evanston, Illinois, United States
• Study site — Detroit, Michigan, United States
• Study site — New Brunswick, New Jersey, United States
• Study site — Somers Point, New Jersey, United States
• Study site — New York, New York, United States
• Study site — New York, New York, United States
• Study site — Rochester, New York, United States
• Study site — Durham, North Carolina, United States
• Study site — Cleveland, Ohio, United States
• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Charlottesville, Virginia, United States
• Study site — Athens, Greece
• Study site — Bologna, Italy
• Study site — Florence, Italy
• Study site — Genova, Italy
• Study site — Pisa, Italy
• Study site — Roma, Italy
• Study site — Rome, Italy
• Study site — Udine, Italy
• Study site — Manchester, United Kingdom
• Study site — Manchester, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.